Veronica Medici
Overview
Explore the profile of Veronica Medici including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zuntini R, Bonora E, Pradella L, Amato L, Vidone M, De Fanti S, et al.
Int J Mol Sci
. 2021 Jun;
22(11).
PMID: 34072463
The NBN gene has been included in breast cancer (BC) multigene panels based on early studies suggesting an increased BC risk for carriers, though not confirmed by recent research. To...
2.
Patel V, Busch E, Friebel T, Cronin A, Leslie G, McGuffog L, et al.
Cancer Res
. 2019 Nov;
80(3):624-638.
PMID: 31723001
Pathogenic sequence variants (PSV) in or () are associated with increased risk and severity of prostate cancer. We evaluated whether PSVs in were associated with risk of overall prostate cancer...
3.
Cortesi L, De Matteis E, Toss A, Marchi I, Medici V, Contu G, et al.
Oncology
. 2017 Aug;
93(6):377-386.
PMID: 28848147
Objective: To evaluate the effectiveness of transvaginal ultrasound (TVU) and serum CA-125 measurement in women at different risk of developing ovarian cancer/fallopian tube cancer (OC/FTC) and the incidence of primary...
4.
Lecarpentier J, Silvestri V, Kuchenbaecker K, Barrowdale D, Dennis J, McGuffog L, et al.
J Clin Oncol
. 2017 Apr;
35(20):2240-2250.
PMID: 28448241
Purpose BRCA1/2 mutations increase the risk of breast and prostate cancer in men. Common genetic variants modify cancer risks for female carriers of BRCA1/2 mutations. We investigated-for the first time...
5.
Zuntini R, Cortesi L, Calistri D, Pippucci T, Martelli P, Casadio R, et al.
Oncotarget
. 2017 Feb;
8(14):22640-22648.
PMID: 28186987
We have investigated the clinical significance of the BRCA1 variant p.His1673del in 14 families from the Emilia-Romagna region of Italy, including 20 breast and 23 ovarian cancer cases; four families...
6.
Peterlongo P, Catucci I, Colombo M, Caleca L, Mucaki E, Bogliolo M, et al.
Hum Mol Genet
. 2015 Jul;
24(18):5345-55.
PMID: 26130695
Numerous genetic factors that influence breast cancer risk are known. However, approximately two-thirds of the overall familial risk remain unexplained. To determine whether some of the missing heritability is due...
7.
Cortesi L, De Nicolo A, Medici V, Marino M, Turchetti D, Pradella L, et al.
Breast Cancer Res Treat
. 2012 Apr;
134(1):435-41.
PMID: 22527099
Unambiguous classification of BRCA1 and BRCA2 variants of uncertain significance (VUS) is a challenging task that vexes health care providers and has profound implications for patients and their family members....
8.
Cortesi L, Masini C, Cirilli C, Medici V, Marchi I, Cavazzini G, et al.
BMC Cancer
. 2010 Mar;
10:90.
PMID: 20219108
Background: The purpose of our study was to compare differences in the prognosis of breast cancer (BC) patients at high (H) risk or intermediate slightly (IS) increased risk based on...
9.
Marino M, Rabacchi C, Simone M, Medici V, Cortesi L, Calandra S
Clin Chim Acta
. 2009 Apr;
403(1-2):249-53.
PMID: 19393826
Background: Point mutations in the highly penetrant cancer susceptibility gene BRCA1 are responsible for the majority of hereditary breast and/or ovarian cancer. We describe a novel large rearrangement of the...